Recombinant Human Monoamine Oxidase B/MAOB/AOFB protein,N-His

Description of Recombinant Human Monoamine Oxidase B/MAOB/AOFB protein,N-His

Introduction

Recombinant Human Monoamine Oxidase B (MAOB) protein, also known as Amine Oxidase, is an enzyme that plays a crucial role in the metabolism of neurotransmitters such as dopamine, serotonin, and norepinephrine. It is a member of the monoamine oxidase family, which are enzymes responsible for the breakdown of monoamine neurotransmitters in the brain. MAOB is a target for drug development in the treatment of neurological disorders such as Parkinson’s disease and depression.

Structure of Recombinant Human MAOB Protein

The human MAOB gene is located on chromosome X and encodes for a protein of 520 amino acids. The recombinant MAOB protein is produced by cloning the gene into a suitable expression vector and expressing it in a host cell. The resulting protein has a molecular weight of approximately 60 kDa and consists of a single polypeptide chain with a flavin adenine dinucleotide (FAD) cofactor. MAOB has a three-dimensional structure that is composed of two domains: the N-terminal domain containing the FAD-binding site and the C-terminal domain responsible for substrate binding and catalysis.

Activity of Recombinant Human MAOB Protein

MAOB is an enzyme that catalyzes the oxidative deamination of monoamine neurotransmitters, converting them into their corresponding aldehydes and ammonia. This process is essential for the regulation of neurotransmitter levels in the brain and is crucial for maintaining proper brain function. In addition to its role in neurotransmitter metabolism, MAOB also has a role in the metabolism of dietary amines and drugs. The activity of MAOB is tightly regulated, and any disruption in its function can lead to neurological disorders.

Application of Recombinant Human MAOB Protein

The recombinant MAOB protein has various applications in both research and medicine. Some of its key applications include:

1. Drug Development

MAOB inhibitors, which block the activity of the enzyme, have been developed and approved for the treatment of Parkinson’s disease. These drugs work by increasing the levels of dopamine in the brain, thereby improving the symptoms of the disease. Recombinant MAOB protein is used in preclinical studies to test the efficacy and safety of potential MAOB inhibitors.

2. Biomarker for Neurological Disorders

MAOB levels have been found to be altered in various neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and depression. Recombinant MAOB protein is used in research to study the role of MAOB in these disorders and to identify potential biomarkers for their diagnosis and progression.

3. Enzyme Replacement Therapy

In rare cases, individuals may have a genetic deficiency of MAOB, leading to a condition called MAOB deficiency. Recombinant MAOB protein can be used as an enzyme replacement therapy to supplement the deficient enzyme and improve the symptoms of the disorder.

4. Production of Antibodies

Recombinant MAOB protein is used to produce antibodies that can specifically bind to MAOB. These antibodies are valuable tools for studying the expression and localization of MAOB in tissues and cells.

5. Research on Neurotransmitter Metabolism

The recombinant MAOB protein is used in research to study the metabolism of monoamine neurotransmitters and to understand the role of MAOB in maintaining their levels in the brain. This research is crucial for developing a better understanding of neurological disorders and identifying potential therapeutic targets.